🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
1.000
+0.090 (9.89%)
Nov 19, 2026, 4:00 PM EST - Market closed

Aardvark Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
60.3447.0561.649.7415.56
Short-Term Investments
0.0162.9812.020.250.55
Cash & Short-Term Investments
60.35110.0373.669.9916.11
Cash Growth
-52.24%49.36%637.44%-37.98%-
Prepaid Expenses
3.761.860.470.250.32
Other Current Assets
---0.130.07
Total Current Assets
64.11111.8974.1410.3716.49
Property, Plant & Equipment
0.530.360.740.160.25
Other Long-Term Assets
0.164.942.640.010.01
Total Assets
64.8117.1877.5110.5416.76

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
1.592.072.31.040.26
Accrued Expenses
5.038.042.290.240.24
Current Portion of Leases
0.410.440.340.110.1
Total Current Liabilities
7.0310.554.931.380.6
Long-Term Leases
0.16-0.440.050.16
Other Long-Term Liabilities
--0.0300.02
Total Liabilities
7.1910.555.391.430.78

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Additional Paid-In Capital
228.69222.473.682.942.61
Retained Earnings
-171.08-115.92-58.33-37.74-30.53
Comprehensive Income & Other
-0.08---
Total Common Equity
57.61106.63-54.64-34.8-27.92
Shareholders' Equity
57.61106.6372.119.115.98
Total Liabilities & Equity
64.8117.1877.5110.5416.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
0.570.440.780.160.26
Net Cash (Debt)
59.78109.5972.889.8315.84
Net Cash Growth
-52.49%50.36%641.67%-37.97%-
Net Cash Per Share
2.745.5818.242.484.07
Filing Date Shares Outstanding
21.8921.8221.73.973.89
Total Common Shares Outstanding
21.8921.824.073.973.89
Working Capital
57.07101.3469.218.9915.9
Book Value Per Share
2.634.89-13.44-8.77-7.18
Tangible Book Value
57.61106.63-54.64-34.8-27.92
Tangible Book Value Per Share
2.634.89-13.44-8.77-7.18
SEC Filings: 10-K · 10-Q